| Photo | Name and a short presentation | CIM |
 | Marcus Prescott Glenton Marcus is MD at St. Olavs Hospital, Trondheim, Norway. He joined Cochrane Sweden when a student in 2021, and has since then published with us four Cochrane reviews: Positioning for lumbar puncture in newborn infants; Olfactory, Vestibular and Multisensory stimulation in preterm infants. He is currently working on two more Cochrane reviews. | From Cochrane Norway (virtual) |
 | Hanneli Timothy & Ellinor Lyberg Hanneli and Ellinor were third-year medical students at Lund University when in 2025 they joined Cochrane Sweden. They worked on a neonatal project on neonatal Individualized developmental care interventions. They have been co-supervised by the Cochrane Croatia team (photo in Split). Looking forward to a new CIM in autumn 2027, for their master thesis! | To Cochrane Croatia |
 | Kristina Shcherbatiuk Kristina Shcherbatiuk is based in Munich, Germany. She started a CIM at our Centre in 2024 and has become coauthor of a systematic review addressing neonatal care, devices for neonatal peripheral catheterization and tip confirmation. Currently she’s involved in a meta-epidemiological study on geographical transportability of randomized evidence in perinatal care, in collaboration with the University Medical Centre Rostock (prof Anna Lene Seidler) and Cochrane Sweden Read more about Kristina | From Germany |
 | Sara Pessano Sara, MD, is based at IRCCS Istituto Giannina Gaslini in Genoa, Italy (Scientific Direction, Clinical Epidemiology Unit). She is coauthor of four published Cochrane reviews led by Cochrane Sweden addressing neonatal care, including lumbar puncture (drugs and position, apnea in preterm infants, and postoperative pain in children. A fifth review is ongoing: Next-Generation Sequencing (NGS) techniques for pre-symptomatic identification of genetic diseases in newborns. Read more about Sara | From Italy, (virtual) |
 | Silvana Urru Silvana is an Italian researcher based in Milan, and part of the Board of Directors of the Alessandro Liberati Association – Cochrane Affiliate Centre. She joined Cochrane Sweden in 2023, and published the Cochrane review Strategies for cessation of caffeine administration in preterm infants. She completed the 2026 the update of the same review. Read more about Silvana | From Italy, (virtual) |
 | Yu-Tian Xiao
Yu-Tian first authored a Cochrane review led by Cochrane Argentina team. In 2023, while medical doctor from China, he joined Cochrane Sweden for the update of cycled light in the neonatal unit, published in 2024 (link). Read more about Yu-Tian here. | From China, (virtual) |
 | Rebecka Carlinger
Rebecka was a medical student at Lund University when in 2023 she worked on a Cochrane review on strategies for caffeine discontinuation in preterm infants, which has been published in 2024 (link). She completed the 2026 the update of the same review. | No |
 | Milena Geist Milena came to Lund for her internship at Cochrane Sweden in 2023, when she was master student, and currently based at LMU Munich, Germany. She worked on several Cochrane reviews with us: strategies for caffeine discontinuation in preterm infants (which has been published in 2024, link; the 2026 update has been submitted); infant positioning for promoting development and preventing morbidity in preterm infants (submitted in 2026); a Cochrane methods tutorial; and late-preterm complications (protocol published in 2026). Read more about Milena here. | Yes from Germany |
 | Alice Sjögren
Alice joined us in January 2023, while medical student at Lund University. She has worked on a Cochrane review on caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants, which has been published in October 2023 (link). | No |
 | Chiara Russo
Chiara visited Cochrane Sweden for three months in 2017, the same year when Cochrane Sweden was launched. At that time, she was finishing medicine, Genova, Italy, via an Erasmus project at Lund University. She has published several Cochrane reviews with Cochrane Sweden: continuous glucose monitoring in preterm infants (2020 and 2021 update); caffeine dosing regimens in preterm infants; and a non-Cochrane review on caffeine. Ongoing Cochrane review: a NMA review on monoclonal antibodies for RSV in children. Read more about Chiara here | From Italy |
 | Martina Albertella
While fifth-year medical student (Genova, Italy), Martina has done an Erasmus project at Lund University in autumn 2022, working on two Cochrane reviews, both published later on: Superoxide dismutase for preventing bronchopulmonary dysplasia (BPD) in preterm infants; Ibuprofen for acute postoperative pain in children. Read more about Martina here | From Italy |
 | Themistoklis Paraskevas Themis (aka ΘΕΜΙΣΤΟΚΛΗΣ ΠΑΡΑΣΚΕΥΑΣ) MD from Patras, Greece, has done an Erasmus project at Lund University in autumn 2022. He published three different types of Cochrane reviews with us: Superoxide dismutase in preterm infants (submitted for publication in October 2022); an overview on pharmacological pain and sedation interventions; a Methods review on neonatal pain scales. Moreover, a meta-research project on trials reporting. Read more about Themis here. | From Greece |
 | Fredh Netterström-Wedin
Fredh is completing his MSc Public Health at Mid Sweden University. Fredh started a CIM at Cochrane Netherlands to learn more on diagnostic test accuracy reviews.
| To Netherlands |
 | Christoper A. Alarcon-Ruiz
Christoper is a Peruvian physician and epidemiologist. He has been a mentee in Cohort 2 - South America from the Cochrane US Network Mentoring Program. In 2022, he joined Cochrane Sweden to co-author a review on human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes. | From US, (virtual) |
 | Luca Tancredi
Luca is a medical doctor based in Augsburg (Germany), specialist in general medicine and geriatrics, PhD candidate at the University of Split, where he did training at Cochrane Croatia and joined Cochrane Sweden via Cochrane International Mobility. Luca co-authored a Cochrane review on postoperative pain in children and a review on human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes. | From Croatia, (virtual) |
 | Johannes Skogler
Johannes was a medical student at Lund University in autumn 2022, when he joined us. He co-authored a review on human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes. | No |
 | Agata Stróżyk
Agata, dietitian, joined Cochrane Sweden in 2022 while conducting her PhD student at the Medical University of Warsaw (Poland). With Cochrane Sweden, she published two Cochrane reviews: an overview on pharmacological pain and sedation interventions; Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis. Read more about Agata here. | From Poland (virtual) |
 | Filip Wikström
Filip was a final-year medical student at Lund University when, in January 2022, he joined Cochrane Sweden. He published a Cochrane review on TNF-alpha inhibitors for juvenile idiopathic arthritis. Filip also enjoyed during a 4-week CIM at Cochrane Iberoamerica (Barcelona), in March 2022. Read more about Filip here. | To Iberoamerica (Barcelona) |
 | Jana Edriss
Jana was a third-year medical student at Lund University when in November 2021 joined Cochrane Sweden. She contributed to a systematic review on diclofenac on acute postoperative pain in children. | No |
 | Tilda Moberg
Tilda was a last year medical student at Lund University when in October 2021 joined Cochrane Sweden. She has published three reviews with our team: human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes; Placenta-associated adverse pregnancy outcomes in women with hyperemesis gravidarum; and the update of a Cochrane review on sustained inflation in newborns. | No |
 | Raphaela Mayrhofer
Raphaela is a neuroscientist based at Södertörn University in Sweden. She joined Cochrane Austria in October 2021, contributing to a systematic review on biologics in rheumatoid arthritis and projects focusing on method evaluation. Read more about Raphaela here. | To Austria |
 | Lea Styrmisdóttir
Lea was a last year medical student at Lund University when in in 2020 she joined Cochrane Sweden, where has become PhD student. First she worked virtually with Cochrane Argentina on a Cochrane review about Palivizumab for preventing respiratory syncytial virus (RSV) infection in children, published in 2021. She then authored additional reviews: a Cochrane review on opioids for neonatal pain in 2023; human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes; a prognostic Cochrane protocol (full review in progress) on prematurity for predicting type 2 diabetes mellitus; a study of Swedish university policies on academic recognition of systematic reviews; a Clinical Trial Transparency Report. | To Cochrane Argentina (virtual) |
 | Marlide Jukema
Marlide was a medical student from Amsterdam, The Netherlands when in 2020 she started her master's with an internship at Cochrane Sweden. Marlide coauthored a systematic review on antileukotrienes (such as montelukast) in newborns, including randomized trials, observational studies and animal studies. Later on she joined another review on opioids in animal models, still to be completed. Also, Marlide translated and recorded a Cochrane podcast on opioids (in Dutch). Read more about Marlide here. | From Netherlands |
 | Marina Macchi
Marina was a last year medical student from Milan, Italy when in 2020 she did her virtual CIM training at Cochrane Sweden. Marina co-authored the Cochrane review update on salbutamol for transient tachypnea of the newborn.
Read more abour Marina here. | From Italy (virtual) |
 | Katarzyna Stempel
Katarzyna was a medical student at Lund University in March 2020. She joined Cochrane Sweden, virtually, due to the corona pandemic. She co-authored a Cochrane review on opioids for postoperative pain in newborns and the protocol of an additional review on opioids and alpha-2-agonists for analgesia and sedation in newborn infants. | No |
 | Mari Kinoshita
Mari is MD, PhD in Perinatal Medicine. She is also a medical doctor trained in neonatology (Japan) with a master’s degree in Public Health (USA). She did her CIM training at Cochrane Sweden in January 2020 as part of a collaboration with Cochrane Japan, alongside her own PhD studies in Lund. With us, she has published three Cochrane reviews on opioids in newborns: opioid regimens for postoperative pain; opioids versus other analgesics and sedatives for postoperative pain; and opioids for procedural pain. Moreover she has published the protocol of an additional review on opioids and alpha-2-agonists for analgesia and sedation in newborn infants. She is leading a review of animal studies on opioids in pups; an ongoing Cochrane NMA review on caffeine; the 2026 Cochrane review update on salbutamol for transient tachypnea of the newborn.
Read more about Mari here. | From Japan |
 | Simon Karlelid
Simon was a last year medical student from Lund University when he started his CIM training with Cochrane South Africa before the corona pandemic. He completed a systematic review on interventions to minimize blood loss in preterm infants, once back at Cochrane Sweden. | To Cochrane South Africa |
 | Israel Borges
Israel is a medical doctor from Belo Horizonte, Brazil. He has been at our Center in January 2020 and then has continued his virtual CIM training at Cochrane Sweden. Israel coauthored to a systematic review on interventions to minimize blood loss in preterm infants and two Cochrane reviews on opioids for postoperative pain in newborns: opioid regimens and opioids versus other analgesics and sedatives. Read more about Israel here. | From Brazil |
 | Emma (Persad) Sinervo
Emma has been trained at Cochrane Austria and currently based in Stockholm, and is member of Cochrane Governing Board. She started her virtual CIM training at Cochrane Sweden in 2020 and then coauthored with us three Cochrane reviews: workplace interventions to reduce the risk of SARS-CoV-2 infection; non-opioid analgesics for neonatal pain; a Methods review on neonatal pain scales. She also published reviews with us on interventions to minimize blood loss in preterm infants; human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes; Placenta-associated adverse pregnancy outcomes in women with hyperemesis gravidarum. Read more about Emma here. | From Austria (virtual) |
 | Ana Pizarro
Ana initiated her virtual CIM while nurse student based at Cochrane Colombia. In 2020 she started her virtual CIM training at Cochrane Sweden. Ana has coauthored three reviews with us: systematic review on caffeine in newborn pups and two Cochrane reviews with Cochrane Sweden: workplace interventions to reduce the risk of SARS-CoV-2 infection; non-opioid analgesics for neonatal pain. Read more about Ana here and here. | From Colombia (virtual) |
 | Greta Sibrecht
Greta is MD PhD from Poznan, Poland. She started her virtual CIM training at Cochrane Sweden in 2020. Over these years, Greta coauthored more than 10 reviews with Cochrane Sweden. Greta is member of the Executive Board of the Cochrane Maternal Neonatal and Children Thematic Group. Read more about Greta here. | From Poland (virtual) |
 | Astrid Modiano Hedenmalm
Astrid was a last year medical student from Lund University. She did her CIM training at Cochrane Netherlands in 2019 for 4 weeks, followed by 16 weeks at our Centre. During this period, she completed a diagnostic test accuracy (DTA) review on continuous glucose monitoring in preterm infants. Read more about Astrid here. | To Cochrane Netherlands |
 | Hanna Peterson
Hanna was a medical student at the Karolinska Institute when she joined Cochrane Sweden for a three-week internship in 2019. During her internship, she coauthored a review on harms of screening. | No |
 | Giulia Bilamour
Giulia was a last year medical student from Italy when she spent two months at Cochrane Sweden during the summer of 2019. She coauthored a review on harms of screening. | From Italy |
 | Franciszek Borys
Franciszek was a medical student from Poznan University of Medical Sciences, Poland when he joined us in Lund worked in 2019 for six weeks. He coauthored more than 10 reviews with us. In 2025, he started a PhD, co-supervised by Matteo. Read more about Franciszek here. | From Poland |
 | Chiara Nava
Chiara was a medical student from Italy when she visited the Centre in 2019 for three months. She has coauthored three reviews with us: a Cochrane review on opioids for neonates receiving mechanical ventilation; a diagnostic test accuracy (DTA) review on continuous glucose monitoring in preterm infants; a review on early vs late caffeine in preterm infants. During her stay, she also wrote a Students for Evidence blog on her Cochrane International Mobility experience. | From Italy |
 | Sandra Nylander Vujovic
Sandra was a last year medical student from Lund University when she did her CIM programme in 2019. She spent four weeks in Denmark with the Cochrane Anaesthesia, Critical and Emergency Care Review Group, followed by 16 weeks at our Centre. She co-authored a review on early vs late caffeine in preterm infants. | To Cochrane Anaesthesia (Denmark) |
 | Karl-Omar Hassan
Karl was a last year medical student from Lund University when in 2019 joined our Centre for 20 weeks. He coauthored a Cochrane overview on interventions on transient tachypnea of the newborn. | No |
 | Kevin Bengtsson
Kevin was a junior medical doctor from Lund University when he did his CIM training at Cochrane Netherlands in 2018 for 3 weeks, followed by 17 weeks at our Centre. During this period, he coauthored a review on use of neonatal pain scales. | To Cochrane Netherlands |
 | Petter Darlison (Brattström)
Petter was a last year medical student from Lund University when he visited our Centre in 2019. He began his Cochrane experience with a four-week training period as an intern in Krems an der Donau at Cochrane Austria, where he was introduced to the methodology of systematic reviews and meta-analysis. This was part of a 20-week research project at our Centre. Petter has coauthored several systematic reviews, including a Cochrane review on caffeine dosing regimens in preterm infants and on decongestants and antihistamines for acute otitis media. One more Cochrane review is ongoing, as part of the PhD he started at Cochrane Sweden in 2023. Petter was also selected to be interviewed by Cochrane on his work as part of their 30 under 30 series. Read the full interview here. | To Cochrane
Austria |
